Seaport Therapeutics is a Boston-based clinical-stage biopharmaceutical company developing new medicines for patients with depression, anxiety and other neuropsychiatric disorders. Its proprietary Glyph platform — licensed from the Porter Research Group at Monash University — applies lymphatic-targeting oral prodrug chemistry so that more medicine reaches the bloodstream and brain while bypassing first-pass liver metabolism and reducing side effects. The clinical pipeline includes GlyphAllo (SPT-300), an oral allopregnanolone prodrug in Phase 2 for major depressive disorder; GlyphAgo (SPT-320), an oral agomelatine prodrug in Phase 2 for generalized anxiety disorder; and Glyph2BLSD (SPT-348), a pre-clinical non-hallucinogenic 2-bromo-LSD neuroplastogen. Seaport publishes no public API, developer portal, SDK or machine-readable specification; its public web surface is a corporate WordPress site plus a hosted investor-relations subdomain.
Seaport Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Pharmaceuticals, Life Sciences, and Clinical Trials.
Regulatory Posture applies to this provider. Its tags matched the
Health regime, so
Regulatory Posture carries 15 points of the composite.
If this regime is wrong for your business, say so on your
provider repo — the
applicability map is public and we will correct it.
The six quality facets above are damped to 85 points between them,
because the conditional facet above carries the other
15. That is why each facet's contribution is shown against a damped
maximum: raising a quality facet moves the composite by 85% of its nominal
weight, not 100%. The full arithmetic is at apis.io/rating/.
aid: seaport-therapeutics
name: Seaport Therapeutics
description: Seaport Therapeutics is a Boston-based clinical-stage biopharmaceutical company developing new medicines for
patients with depression, anxiety and other neuropsychiatric disorders. Its proprietary Glyph platform — licensed from the
Porter Research Group at Monash University — applies lymphatic-targeting oral prodrug chemistry so that more medicine reaches
the bloodstream and brain while bypassing first-pass liver metabolism and reducing side effects. The clinical pipeline includes
GlyphAllo (SPT-300), an oral allopregnanolone prodrug in Phase 2 for major depressive disorder; GlyphAgo (SPT-320), an oral
agomelatine prodrug in Phase 2 for generalized anxiety disorder; and Glyph2BLSD (SPT-348), a pre-clinical non-hallucinogenic
2-bromo-LSD neuroplastogen. Seaport publishes no public API, developer portal, SDK or machine-readable specification; its
public web surface is a corporate WordPress site plus a hosted investor-relations subdomain.
url: https://raw.githubusercontent.com/api-evangelist/seaport-therapeutics/refs/heads/main/apis.yml
deliveryModel:
model: saas
open_source: false
commercial: true
callable_host: false
label: Hosted service · you call their endpoint
confidence: medium
source:
- pricing
generated: '2026-08-28'
method: derived
accessModel:
pricing: unknown
onboarding: unknown
trial: false
try_now: false
public: false
label: Unknown
confidence: low
source:
- security
generated: '2026-09-02'
method: derived
image: https://seaporttx.com/wp-content/uploads/2023/11/seaport_logo.png
x-type: company
x-source: harvest:secondary-market
specificationVersion: '0.20'
created: '2026-08-26'
modified: '2026-08-26'
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Life Sciences
- Clinical Trials
- Neuroscience
- Drug Delivery
apis: []
maintainers:
- FN: Kin Lane
email: kin@apievangelist.com
- FN: APIs.json
email: info@apis.io
common:
- type: DomainSecurity
url: security/seaport-therapeutics-domain-security.yml
- type: Website
url: https://seaporttx.com/
- type: PrivacyPolicy
url: https://seaporttx.com/privacy-policy/
- type: TermsOfService
url: https://seaporttx.com/terms-of-use/
x-enrichment:
date: '2026-08-26'
status: minimal
artifacts_added: 2
pass: local-v1
x-coverage:
state: none
reason: not-a-software-company
detail: Seaport Therapeutics is a clinical-stage neuropsychiatric drug developer whose product is the Glyph oral-prodrug
platform, not software; seaporttx.com is a corporate WordPress site that returns a real 404 on every OpenAPI, GraphQL,
llms.txt and /.well-known/ path, and its only machine-readable document is the WordPress core /wp-json/ discovery index
that ships with the CMS.
evidence:
- url: https://seaporttx.com/openapi.json
status: 404
- url: https://seaporttx.com/llms.txt
status: 404
- url: https://seaporttx.com/.well-known/agent-card.json
status: 404
- url: https://seaporttx.com/wp-json/
status: 200
- url: https://investors.seaporttx.com/
status: 0
checked: '2026-08-26'